Finland· FI-REL-REL56349
Beovu
A brolucizumab product containing brolucizumab, registered in Finland by Novartis Europharm Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Brolucizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC S01LA06 (brolucizumab), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Brolucizumab · ATC S01LA06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Brolucizumab
- Manufacturer
- Novartis Europharm Limited
- Country
- Finland (FI)
- ATC code
- S01LA06
- ATC class
- Brolucizumab
- Defined daily dose
- 0.0357 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brolucizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandBeovuNovartis Europharm Limited*
- CzechiaBEOVUNovartis Europharm Limited, Dublin
- SwedenBeovu 120 mg/ml Injektionsvätska, lösningNovartis Europharm Limited
- BelgiumBeovu 120 mg/mlNovartis Europharm
- FranceBEOVU 120 mg/ml, solution injectable en seringue préremplieNOVARTIS EUROPHARM (IRLANDE)
- United KingdomBeovu 19.8mg/0.165ml solution for injection pre-filled syringesNovartis Pharmaceuticals UK Ltd
- IrelandBeovu 120 mg/ml solution for injection in pre-filled syringeNovartis Europharm Limited
- Japanブロルシズマブ（遺伝子組換え）ノバルティス ファーマ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beovu
- Liechtenstein · Beovu
- Norway · Beovu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/39f02577-7847-4470-8695-3a7338ccb3a1 GET /v1/drugs/39f02577-7847-4470-8695-3a7338ccb3a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos, esitäytetty ruisku",
"route": "Silmän lasiaiseen",
"ddd_unit": null,
"strength": "120 mg/ml",
"atc_label": "brolusitsumabi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/19/1417/001",
"fimea_rel_id": "REL56349",
"authorised_at": "2020-02-13"
}See everything about brolucizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.